Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V6OK
|
|||
| Drug Name |
PMID28048944-Compound-5
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
KADMON CORPORATION, LLC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H18N6O
|
|||
| Canonical SMILES |
COC1=CC2=C(CN(C2)C3=NC=CC(=N3)NC4=CC5=C(C=C4)NN=C5)C=C1
|
|||
| InChI |
1S/C20H18N6O/c1-27-17-4-2-13-11-26(12-15(13)9-17)20-21-7-6-19(24-20)23-16-3-5-18-14(8-16)10-22-25-18/h2-10H,11-12H2,1H3,(H,22,25)(H,21,23,24)
|
|||
| InChIKey |
SWHUIIODYNUMNO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Rho kinase inhibitors: a patent review (2014 - 2016).Expert Opin Ther Pat. 2017 Apr;27(4):507-515. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.